Pro zobrazení tohoto obsahu je třeba být přihlášen.
Categories for Uncategorized
ADULT PATIENTS WITH ACUTE MYELOID LEUKEMIA (AML) WHO REQUIRE TWO COURSES OF INDUCTION THERAPY TO ACHIEVE COMPLETE REMISSION (CR) SHOULD UNDERGO ALLOGENEIC TRANSPLANT (ALLO-SCT) DURING THE FIRST CR
15 októbra, 2020 7:26 pmAuthor(s): Hiroaki Shimizu, Hiroshi Handa, Nahoko Hatsumi, et. al. Abstract: ABSSUB-4989 Session topic: 4. Acute myeloid leukemia –...
RESULTS OF A PHASE 3, MULTICENTER, RANDOMIZED, OPEN-LABEL STUDY OF AZACITIDINE (AZA) VS CONVENTIONAL CARE REGIMENS (CCR) IN OLDER PATIENTS WITH NEWLY DIAGNOSED ACUTE MYELOID LEUKEMIA (AML)
15 októbra, 2020 7:26 pmAuthor(s): Hervé Dombret, John F. Seymour, Aleksandra Butrym, et. al. Abstract: LB-6212 Session topic: 4. Acute myeloid leukemia...
VALIDATION OF EUROPEAN LEUKEMIA NET (ELN) GUIDELINES FOR CYTOGENETICALLY NORMAL AML IN ASSOCIATION WITH NPM1 AND FLT3-ITD MUTATIONS: FURTHER STRATIFICATION FOCUSING ON WT1 EXPRESSION
15 októbra, 2020 7:26 pmAuthor(s): Jae-Ho Yoon, Hee-Je Kim, Young-Woo Jeon, et. al. Abstract: ABSSUB-3999 Session topic: 4. Acute myeloid leukemia –...
Akútna myeloblastová leukémia
15 októbra, 2020 7:26 pmKongres potvrdil významný pokrok v poznatkoch o patogenéze akútnej myeloblastovej leukémie (AML), v rozvoji diagnostických vyšetrení a nových terapií. Rozlúštil sa molekulovogenetický a epigenetický základ...
5-YR RESULTS FROM THE PIVOTAL PHASE 2 PONATINIB PACE TRIAL: EFFICACY, SAFETY AND LANDMARK ANALYSIS IN HEAVILY PRETREATED PATIENTS (PTS) WITH CHRONIC-PHASE CHRONIC MYELOID LEUKEMIA (CP-CML)
15 októbra, 2020 7:26 pmAuthor(s): Jorge E Cortes, Hagop M Kantarjian, Javier Pinilla-Ibarz, et. al. Abstract: P 603 Session topic: 8. Chronic...
ASSESSMENT OF IMATINIB 400MG AS FIRST LINE TREATMENT OF CHRONIC MYELOID LEUKEMIA: 10 -YEAR SURVIVAL RESULTS OF THE RANDOMIZED CML STUDY IV
15 októbra, 2020 7:26 pmAuthor(s): Ruediger Hehlmann, Michael Lauseker, Susanne Saussele et. al. Abstract: S 424 Session topic: 8. Chronic myeloid leukemia...
DURABLE TREATMENT-FREE REMISSION (TFR) AFTER STOPPING SECOND-LINE NILOTINIB (NIL) IN PATIENTS (PTS) WITH CHRONIC MYELOID LEUKEMIA IN CHRONIC PHASE (CML-CP): ENESTOP 96-WK UPDATE
15 októbra, 2020 7:26 pmAuthor(s): Timothy Hughes, Carla Boquimpani, Naoto Takahashi, et al Abstract: P 257 Session topic: 8. Chronic myeloid leukemia...
IMPACT OF ARTERIAL THROMBOTIC EVENTS ON THE LONG-TERM OUTCOME OF CHRONIC MYELOID LEUKEMIA (CML) PATIENTS TREATED IN FIRST-LINE WITH NILOTINIB: AN ANALYSIS OF THE GIMEMA CML WORKING PARTY
15 októbra, 2020 7:26 pmAuthor(s): Gabriele Gugliotta, Fausto Castagnetti, Massimo Breccia, et. al. Abstract: P 605 Session topic: 8. Chronic myeloid leukemia...
Aktuality z EHA 2017 zaměřené na chronickou myeloidní leukemii
15 októbra, 2020 7:26 pmChronická myeloidní leukemie (CML) je klonální myeloproliferativní onemocnění, které představuje 15–25 % nově diagnostikovaných leukemií dospělého věku. Je příkladem onemocnění, u kterého...
COMBINATION THERAPY OF POMALIDOMIDE PLUS RUXOLITINIB IN MYELOFIBROSIS: RESULTS FROM COHORT 1 OF THE MPNSG-0212 TRIAL (NCT01644110)
15 októbra, 2020 7:26 pmAuthor(s): Frank Stegelmann, Martin Griesshammer, Steffen Koschmieder Abstract: P 700 Session topic: 16. Myeloproliferative neoplasms – Clinical ...